Marcello Bellusci

Dr. Marcello Bellusci


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2017 in Epilepsia
Verified
Journal Article
Closed access
PDF file
NSNicola Specchio
Nicola Specchio
MBMarcello Bellusci
Marcello Bellusci
NPNicola Pietrafusa
Nicola Pietrafusa
MTMarina Trivisano
Marina Trivisano
LPLuca De Palma
Luca De Palma
FVFederico Vigevano
Federico Vigevano

1 July 2016 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
MGM. Gijón
M. Gijón
MBMarcello Bellusci
Marcello Bellusci
BPB. Petraitiene
B. Petraitiene
ANAntoni Noguera-Julian
Antoni Noguera-Julian
VZV. Zilinskaite
V. Zilinskaite
PCP. Rojo Conejo
P. Rojo Conejo

6 February 2018 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
EMElena Martín-Hernández
Elena Martín-Hernández
MRMaría Elena Rodríguez-García
María Elena Rodríguez-García
CCChun-An Chen
Chun-An Chen
FCFrancisco Javier Cotrina-Vinagre
Francisco Javier Cotrina-Vinagre
PCPatricia Carnicero-Rodríguez
Patricia Carnicero-Rodríguez
FMFrancisco Martínez-Azorín
Francisco Martínez-Azorín

3 May 2019 in European Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
MRMaría Elena Rodríguez-García
María Elena Rodríguez-García
FCFrancisco Javier Cotrina-Vinagre
Francisco Javier Cotrina-Vinagre
MBMarcello Bellusci
Marcello Bellusci
AAAna Martínez de Aragón
Ana Martínez de Aragón
LHLaura Hernández-Sánchez
Laura Hernández-Sánchez
FMFrancisco Martínez-Azorín
Francisco Martínez-Azorín

1 June 2018 in Pediatric Emergency Care
Verified
Journal Article
Closed access
PDF file
RNRaquel Núñez-Ramos
Raquel Núñez-Ramos
SMSoledad Montoro
Soledad Montoro
MBMarcello Bellusci
Marcello Bellusci
MFMaría Rosa del Fresno-Valencia
María Rosa del Fresno-Valencia
MGMarta Germán-Díaz
Marta Germán-Díaz
JMJavier Manzanares
Javier Manzanares
Purpose: The aims of this study were to analyze the characteristics of patients with acute liver failure (ALF) in our center and evaluate the prognostic value of the Pediatric End-Stage Liver Disease (PELD) score calculated at admission. Methods: A retrospective analysis of patients with ALF younger than 15 years between 2005 and 2013 was performed. Information collected included age, sex, etiology of ALF, laboratory tests, PELD score, stage of encephalopathy, and need for liver support devices such as MARS and/or liver transplant (LT) and survival. A poor prognosis was defined as the need for LT or death. Results: Twenty patients (10 male patients, 50%) with a median age of 2.6 years (3 days-14.5 y old) were included. Acute liver failure was of indeterminate cause in 5 cases (25%). Within the recognized causes, the most frequent were viral hepatitis (herpes simplex virus, adenovirus, influenza B, Epstein-Barr virus), autoimmune hepatitis, and metabolopathies. Sixty percent presented with encephalopathy at diagnosis. Four patients were aided by a MARS liver support device. Six patients received a total of 7 transplants, all from deceased donors. The rate of spontaneous recovery was 45%. Currently 13 patients (65%) are living, 4 of them with an LT. Six patients died because of ALF. The mean PELD score of patients with spontaneous recovery was 15.31 (5.3–27.6) compared with a mean of 29.5 (17.2–39.4) in LT patients and 31.55 (15.8–52.4) for nonsurvivors (P = 0.013). Conclusions: High PELD scores at diagnosis were accurate predictors of a poor prognosis in our patients with ALF. This model may help in the clinical management of this entity, although prospective validation is needed.

20 March 2020 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
MGManuel Gijón
Manuel Gijón
MBMarcello Bellusci
Marcello Bellusci
BPBirute Petraitiene
Birute Petraitiene
ANAntoni Noguera-Julian
Antoni Noguera-Julian
DGDaniel Glikman
Daniel Glikman
PRPablo Rojo
Pablo Rojo
To analyze host and pathogen factors related to disease severity of community-acquired bone and joint infections in children, a cohort of pediatric patients was prospectively recruited from 13 centers in 7 European countries. A total of 85 children were included, 11 (13%) had a severe infection. Panton-Valentine leukocidin–positive isolates were 17%, and 6% of the isolates were methicillin-resistant Staphylococcus aureus . Multivariate analysis identified Panton-Valentine leukocidin presence (adjusted odds ratio, 12.6; P = 0.01) as the only factor independently associated with severe outcome, regardless of methicillin resistance.